Seer Biosciences

Our goal is to empower the scientific community with tools that help them to achieve exceptional outcomes by removing the technological barriers to studying the proteome. Our technology is designed to enable breakthrough studies to happen by taking deep proteomics from a pinhole to a panorama.

Over the last 15 years, the fields of genomics and transcriptomics have undergone an explosion in content and discovery, fueled by massively parallel technologies that made large-scale studies possible and tractable. Advancement in those fields have deepened our understanding of biology and ushered in new companies, applications and diagnostics solutions that impact everyday human life.

Similar capabilities have evaded the field of proteomics. As a result, researchers have been forced into a tradeoff: the scale of the study, or the depth of its coverage. Until now. We’re committed to eliminating the obstacles that have kept proteomics’ potential from matching the pace of advancements we’ve seen in other fields. We believe that unbiased, deep, rapid, large-scale proteomics can, and must, become accessible to the broad scientific community so that we may significantly advance our understanding of biology, health, and disease. And this will require solutions that allow researchers to accurately survey and analyze the full diversity of proteins across individuals, over time.  

Stock Symbol: SEER

CONNECT